Beyond the Lab – Episode 4

by Shreesha V | Sep 30, 2024 | Research

Beyond the Lab Episode 4 🚨 The 4th episode of our Beyond the Lab interview series is now live! 🎉   In this episode, we talk with Cali Roiboit, a Provisional Psychologist and PhD candidate in Clinical Neuropsychology at Monash University. Cali’s research focuses...

Beyond the Lab – Episode 3

by Carly Jevric | Aug 28, 2024 | Research

Beyond the Lab Episode 3 🚨 The 3rd episode of our Beyond the Lab interview series is now live! 🎉   In this episode, we speak with a Clinical Trial Manager, Ajantha Rajasekar about the ethical advancements in clinical trials, the importance of informed consent, and how...

SKY-0515 Clinical Trial

by Shreesha V | Aug 27, 2024 | Research

SKY-0515 Clinical Trial A Small Molecule Promises Big! In February 2024, Skyhawk Therapeutics, a biotechnology company at the forefront of developing innovative treatments, made a significant progress in the fight against Huntington’s disease. With no approved...

The AMT-130 Study

by Shreesha V | Jul 17, 2024 | Research

The AMT-130 Study An Exciting development in the Huntington’s research space. uniQure has released encouraging interim results from the AMT-130 therapy trials for Huntington’s Disease (HD). Since the trials began, AMT-130 has faced some challenges. Initial...

SELECT-HD Trial Update

by Shreesha V | Jul 16, 2024 | Research

SELECT-HD Trial Update A promising step forward for the Huntington’s Disease Community Wave Life Sciences Ltd. recently announced positive results from their SELECT-HD trial (NCT05032196), a global multicenter, double-blind, placebo-controlled, Phase 1b/2a...

SURVEYOR: Clinical Trial Update

by Shreesha V | Jun 17, 2024 | Research

A news update from SAGE therapeutics !! We are excited to announce ground-breaking results from SURVEYOR, a clinical trial focused on cognitive changes in individuals with Huntington’s disease (HD). This trial tested the short-term safety and efficacy of...